Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27522 | 187 | 37.1 | 75% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 495 | 14696 | RADIATION RESEARCH//INTERNATIONAL JOURNAL OF RADIATION BIOLOGY//AMIFOSTINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | GS NITROXIDE | Author keyword | 6 | 100% | 2% | 4 |
| 2 | LECITHINIZED SUPEROXIDE DISMUTASE | Author keyword | 4 | 46% | 3% | 6 |
| 3 | P INFECT ONCOL | Address | 3 | 57% | 2% | 4 |
| 4 | LECITHINIZED SUPEROXIDE DISMUTASE PC SOD | Author keyword | 3 | 100% | 2% | 3 |
| 5 | JP4 039 | Author keyword | 3 | 60% | 2% | 3 |
| 6 | PC SOD | Author keyword | 3 | 60% | 2% | 3 |
| 7 | RADIATION MITIGATION | Author keyword | 3 | 42% | 3% | 5 |
| 8 | QUINOTOLAST | Author keyword | 2 | 67% | 1% | 2 |
| 9 | RADIOPROTECTIVE GENE THERAPY | Author keyword | 2 | 67% | 1% | 2 |
| 10 | MNSOD PL | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GS NITROXIDE | 6 | 100% | 2% | 4 | Search GS+NITROXIDE | Search GS+NITROXIDE |
| 2 | LECITHINIZED SUPEROXIDE DISMUTASE | 4 | 46% | 3% | 6 | Search LECITHINIZED+SUPEROXIDE+DISMUTASE | Search LECITHINIZED+SUPEROXIDE+DISMUTASE |
| 3 | LECITHINIZED SUPEROXIDE DISMUTASE PC SOD | 3 | 100% | 2% | 3 | Search LECITHINIZED+SUPEROXIDE+DISMUTASE+PC+SOD | Search LECITHINIZED+SUPEROXIDE+DISMUTASE+PC+SOD |
| 4 | JP4 039 | 3 | 60% | 2% | 3 | Search JP4+039 | Search JP4+039 |
| 5 | PC SOD | 3 | 60% | 2% | 3 | Search PC+SOD | Search PC+SOD |
| 6 | RADIATION MITIGATION | 3 | 42% | 3% | 5 | Search RADIATION+MITIGATION | Search RADIATION+MITIGATION |
| 7 | QUINOTOLAST | 2 | 67% | 1% | 2 | Search QUINOTOLAST | Search QUINOTOLAST |
| 8 | RADIOPROTECTIVE GENE THERAPY | 2 | 67% | 1% | 2 | Search RADIOPROTECTIVE+GENE+THERAPY | Search RADIOPROTECTIVE+GENE+THERAPY |
| 9 | MNSOD PL | 1 | 100% | 1% | 2 | Search MNSOD+PL | Search MNSOD+PL |
| 10 | MNSOD PL GENE THERAPY | 1 | 100% | 1% | 2 | Search MNSOD+PL+GENE+THERAPY | Search MNSOD+PL+GENE+THERAPY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PLASMID LIPOSOME DELIVERY | 24 | 91% | 5% | 10 |
| 2 | MNSOD PL | 15 | 82% | 5% | 9 |
| 3 | GS NITROXIDE JP4 039 | 12 | 86% | 3% | 6 |
| 4 | PC SOD | 11 | 78% | 4% | 7 |
| 5 | INTRATRACHEAL INJECTION | 10 | 61% | 6% | 11 |
| 6 | SUPEROXIDE DISMUTASE TRANSGENE | 6 | 80% | 2% | 4 |
| 7 | MNSOD TRANSGENE | 6 | 100% | 2% | 4 |
| 8 | ADIPOCYTOGENESIS | 4 | 75% | 2% | 3 |
| 9 | CONFERS RADIOPROTECTION | 2 | 67% | 1% | 2 |
| 10 | SMAD3 MICE | 2 | 67% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Gene therapy for radioprotection | 2015 | 1 | 97 | 28% |
| Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization | 2007 | 37 | 57 | 30% |
| Radioprotective gene therapy | 2011 | 5 | 144 | 15% |
| Allylic Amines as Key Building Blocks in the Synthesis of (E)-Alkene Peptide Isosteres | 2012 | 13 | 69 | 9% |
| Therapeutic strategies by modulating oxygen stress in cancer and inflammation | 2009 | 145 | 104 | 3% |
| Gene therapy approaches for stem cell protection | 2008 | 11 | 55 | 11% |
| Radioprotection | 2009 | 26 | 100 | 9% |
| The diverse and complex roles of radiation on cancer treatment: therapeutic target and genome maintenance | 2012 | 1 | 80 | 8% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | P INFECT ONCOL | 3 | 57% | 2.1% | 4 |
| 2 | GRP PHARMACOL CANC TREATMENT | 1 | 40% | 1.1% | 2 |
| 3 | MED COUNTERMEASU RADIAT | 1 | 33% | 1.1% | 2 |
| 4 | 2MIYAMAE KU | 1 | 50% | 0.5% | 1 |
| 5 | FRONTIER MEDMIYAMAE KU | 1 | 50% | 0.5% | 1 |
| 6 | MOL ONCOL SOLID TUMORS G360 | 1 | 50% | 0.5% | 1 |
| 7 | PHARMACOL CANC TREATMENT G402 | 1 | 50% | 0.5% | 1 |
| 8 | PUBL HLTH BIOSTAT RADIOL | 1 | 50% | 0.5% | 1 |
| 9 | STUDENT UNION | 1 | 50% | 0.5% | 1 |
| 10 | MOL SCREENING SHARED OURCE | 0 | 33% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000177202 | RADIATION PNEUMONITIS//RADIATION INDUCED LUNG INJURY//RADIATION INDUCED LUNG TOXICITY |
| 2 | 0.0000153195 | MNSOD//MANGANESE SUPEROXIDE DISMUTASE//SOD2 |
| 3 | 0.0000123028 | GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL |
| 4 | 0.0000119731 | MITOENGN//OXYS RATS//SKQ1 |
| 5 | 0.0000103062 | MED CLIN 9//SECT RECONSTRUCT PLAST SURG//BIOMED ENGN IMAGING |
| 6 | 0.0000095136 | MNTE 2 PYP5//SOD MIMIC//MNTE 2 PYP |
| 7 | 0.0000094458 | ENDOGENOUS ANTIOXIDANT DEFENCE//MELON EXTRACT//ORGOTEIN |
| 8 | 0.0000083183 | EXTRACELLULAR SUPEROXIDE DISMUTASE//EC SOD//EXTRACELLULAR SUPEROXIDE DISMUTASE EC SOD |
| 9 | 0.0000078749 | AMIFOSTINE//WR 2721//RADIOPROTECTION |
| 10 | 0.0000070857 | RADIAT COUNTERMEASU PROGRAM//ARMED FORCES RADIOBIOL//ACUTE RADIATION SYNDROME |